https://www.prognyx.com/blog/j-j-s-reported-785m-upfront-for-sail-comes-with-a-2-58b-option-on-in-vivo-car-tPrognyxen2026-07-30J J's reported $785M upfront for Sail comes with a $2.58B option on in vivo CAR-T — and almost no clinical record to price it against https://www.prognyx.com/blog/replimune-s-own-filing-shows-the-rp1-melanoma-pivotal-was-a-single-arm-cohort-thPrognyxen2026-07-29Replimune's own filing shows the RP1 melanoma pivotal was a single-arm cohort — the randomized answer is dated 2030